Related Experiment Video
Updated: Aug 22, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
A Hemodynamic Scoring System for Optimizing Transcatheter Arterialization of the Deep Veins in No-Option Patients
Michael C Siah1, Syed Muhammad Mashhood Ali Bokhari1, Anahita Dua2
1Division of Vascular Surgery, UT Southwestern Medical Center, Dallas, Texas.
Insights
A new Transcatheter Arterialization of the Deep Veins (TADV) scoring system helps select optimal crossing sites for chronic limb-threatening ischemia (CLTI) patients. This tool correlates with reduced pain and lower amputation risk, improving outcomes.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Imaging
Background:
- Transcatheter arterialization of the deep veins (TADV) is an emerging revascularization strategy for high-risk chronic limb-threatening ischemia (CLTI).
- Variability in TADV outcomes necessitates structured tools for optimizing arteriovenous crossing-site selection and perfusion.
- An angiographic scoring system is proposed to quantify the hemodynamic impact of donor artery selection in TADV procedures.
Purpose of the Study:
- To develop and evaluate an angiographic TADV scoring system.
- To quantify the hemodynamic impact of donor artery selection in TADV.
- To assess the association between the TADV score and clinical outcomes in CLTI patients.
Main Methods:
- Retrospective analysis of 43 patients from the PROMISE II trial with Rutherford class 5-6 CLTI.
- Calculation of a TADV score (-4 to +4) based on pre- and postprocedural angiograms, integrating arterial contribution and crossing-site selection.
- Assessment of primary outcome (pain reduction) and secondary outcomes (limb salvage, amputation-free survival, wound healing) using regression analyses.
Main Results:
- 100% technical success with significant pain reduction from 5.1 to 1.4 at 2 years.
- At 2 years, limb salvage was 60.7%, amputation-free survival 35.9%, and wound healing 62.5%.
- The TADV score demonstrated high reliability (ICC 91.7%) and correlated with reduced pain and major amputation risk.
Conclusions:
- The angiographic TADV score is a reliable tool for quantifying hemodynamic impact in TADV procedures.
- The TADV score correlates with early pain reduction and reduced risk of major amputation in CLTI patients.
- This scoring system can potentially optimize crossing-site selection and improve outcomes for no-option CLTI patients.
Background:
Transcatheter arterialization of the deep veins (TADV) with LimFlow (Stryker Peripheral Vascular) is an emerging revascularization strategy for patients with high-risk chronic limb-threatening ischemia (CLTI). Variability in outcomes highlights the need for structured tools to guide arteriovenous crossing-site selection and optimize perfusion. We propose an angiographic TADV scoring system to quantify the hemodynamic impact of donor artery selection and evaluate its association with clinical outcomes.
Methods:
This retrospective analysis included 43 randomly selected patients from the PROMISE II trial with Rutherford class 5 to 6 no-option CLTI. Pre- and postprocedural angiograms were reviewed, and a TADV score (-4 to +4; lower scores indicating worse residual foot perfusion) was calculated by integrating below-the-knee arterial contribution with crossing-site selection. The primary outcome was change in ischemia-related pain. Secondary outcomes included limb salvage, amputation-free survival, wound healing, and secondary patency. Intraclass correlation coefficient assessed score reliability. Linear regression evaluated associations between TADV score and pain, and Cox regression assessed the relationship between pain and major amputation.
Results:
Technical success was 100%. Mean pain decreased from 5.1 at baseline to 1.4 at 2 years, with median pain reaching 0 by 9 months. At 2 years, limb salvage was 60.7%, amputation-free survival 35.9%, and complete wound healing 62.5%. Intraclass correlation coefficient for the TADV score was 91.7%. Higher TADV scores were associated with lower pain at 1 and 3 months. Each one-point increase in pain increased major amputation risk (hazard ratio, 1.20; 95% CI, 1.02-1.41).
Conclusions:
The TADV score correlates with early pain reduction and amputation risk, supporting its potential role in optimizing crossing-site selection and outcomes in no-option CLTI.
More Related Videos
Related Concept Videos
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care

